Axiom Investment Management’s Organon & Co OGN Stock Holding History

Axiom Investment Management’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-15	Closed	–	–	313
2022 Q3	$0	Buy	+15	New	+$453	﹤0.01%	446

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Axiom Investment Management's OGN Position: Q4 2022 in Review

Axiom Investment Management sold out of Organon & Co (OGN) in Q4 2022, closing a stake of 15 shares.

Axiom Investment Management first reported a position in OGN in Q3 2022 and held it in 1 quarter. The position peaked at $0 in Q3 2022. 821 funds tracked by Wall St. Rank hold OGN as of Q4 2022.

Axiom Investment Management reported no remaining Organon & Co position as of Q4 2022 after selling out during the quarter.
Axiom Investment Management sold 15 Organon & Co shares in Q4 2022.
Axiom Investment Management first reported a position in Organon & Co in Q3 2022 and held it in 1 quarter.
Axiom Investment Management's Organon & Co position peaked at $0 in Q3 2022.
821 funds tracked by Wall St. Rank held Organon & Co as of Q4 2022.

Based on Axiom Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.